What Went Wrong with AstraZeneca’s Vaccine Trial? CEO Only Shares Details with Investors
As the world races to find a COVID-19 vaccine, one of the most promising vaccine trials has hit a major roadblock. AstraZeneca paused its Phase 3 COVID-19 vaccine trial after a woman in the trial developed severe neurological symptoms consistent with transverse myelitis, or inflammation of the spinal cord.